How much funding has Sino Biological raised?

Sino Biological has raised $29.0M in total funding, most recently a Series A round.

Who are Sino Biological's investors?

Sino Biological's investors include Qiming VP.

When was Sino Biological founded?

Sino Biological was founded in 2007.

Where is Sino Biological headquartered?

Sino Biological is headquartered in Beijing, China.

What industry is Sino Biological in?

Sino Biological operates in Biotech, Life Sciences.

How many employees does Sino Biological have?

Sino Biological has 501-1000 employees.

Sino Biological

IPO

Global Leader in Recombinant Technology for Life Science

Beijing, China · Founded 2007 · $29.0M raised

Biotech

Life Sciences

Headquarters: Beijing
Employees: 501–1000
Founded: 2007
Business Model: B2B

Website: sinobiological.com
Total Funding: $29.0M
Last Round: $29.0M Series AMay 2018
Rounds: 1

About

Sino Biological is an international reagent supplier and service provider specializing in independently developed recombinant proteins, antibodies, and cDNA clones for life science research. The company serves academic institutions, biotech firms, and pharmaceutical companies with one-stop technical services, including pre-clinical production for monoclonal antibody drug candidates, and operates from headquarters in Beijing with subsidiaries and production facilities in the United States, Europe, and Japan. Sino Biological employs over 900 research staff, including 230+ with master's or PhD degrees, across more than 279,800 sq ft of lab and office space.

Summary

Sino Biological is a Biotech company based in Beijing, China, founded in 2007. It has raised $29.0M in total across 1 round, most recently a $29.0M Series A round in May 2018. Investors include Qiming VP.